Royalty Report: Medical, Drugs, Therapeutic – Collection: 27284


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3

Primary Industries

  • Medical
  • Drugs
  • Therapeutic
  • Device
  • Diagnostic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 27284

License Grant
The Licensor granted the Company a worldwide license for vaginal use of the BufferGel Technology without the SoftCup Technology.
License Property
BufferGel Technology for contraception and the prevention of AIDS and other STDs.  BufferGel Technology has the ability to maintain the normal vaginal pH balance while killing sperm and most STD pathogens.
Field of Use
The Field of Use apply to the women's health care market.

IPSCIO Record ID: 241274

License Grant
The Parties entered a License Agreement for the commercialization of the one-year vaginal system for contraception in the territory.
License Property
The product is the investigational segesterone acetate/ethinyl estradiol one-year vaginal system for contraception.  The one-year vaginal contraceptive system is in the shape of a ring and combines a novel progestin, segesterone acetate (Nestorone®), with a widely used estrogen (ethinyl estradiol) to prevent ovulation for an entire year (13 cycles).
Field of Use
The field of use is contraception.

IPSCIO Record ID: 382626

License Grant
Licensor grants Swiss Licensee to sell Licensor woman’s licensed diagnostic product VS-Sense in Mexico.
License Property
VS-Sense is a vaginal health diagnostic medical device.

The VS-SENSEâ„¢ TEST is a qualitative, visually-read swab for clinicians who wish to evaluate women with vaginal symptoms to rule out or rule in Bacterial Vaginosis and Trichomoniasis. The test indicates by color change whether a vaginal secretion has disordered acidity parameters. Results are based on combined indication of pH level and buffer capacity (watery secretion) which characterizes Bacterial Vaginosis and Trichomoniasis.

The VS-SENSEâ„¢ Test indicates abnormal vaginal discharge acidity by identifying changes in the pH level. The test cutoff is set at pH 4.7 (+0.3/-0.2 pH units; there may be variations due to sensitivity to buffer capacity). When the vaginal secretion has a pH above this cutoff, the test tip will be stained (or partially stained) green or blue. The test, when combined with clinical examination, assists the physician in diagnosing conditions which are associated with elevated pH levels.

Field of Use
The licensed product is used for diagnosing vaginal health in women.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.